A Prospective Observational Study of Senaparib in the Treatment of Epithelial Ovarian Cancer

NCT07586449 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer (OvCa)

Interventions

DRUG: Senaparib capsules(20mg)

Sponsor

Zhejiang Cancer Hospital